Found 17 matching trials
Cytokine Induced Memory-like NK Cell Adoptive Therapy for Relapsed AML After Allogeneic Hematopoietic Cell Transplant PHASE1 Donor Lymphocyte Infusion (DLI) following salvage chemotherapy is the one o...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Innate Donor Effector Allogeneic Lymphocyte Infusion After Stem Cell Transplantation: the IDEAL Trial PHASE2 The curative principle behind allogeneic hematopoietic stem cell transplant...
Show More Location
Copenhagen University Hospital, Rigshospitalet
Learn More & Join Trial
Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies NA This study is being done to assess the safety and determine the maximum tol...
Show More Location
UW Carbone Cancer Center
Learn More & Join Trial
NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) PHASE1 This is a phase I/II study of highly selected donor lymphocyte infusions in...
Show More Location
Universitätsklinikum
Learn More & Join Trial
Prophylactic and Therapeutic DLI-X for Leukemia Relapse After HCT PHASE1 The primary objective of this proposal is to conduct the first-in-human ran...
Show More Location
The University of Arizona Cancer Center
Learn More & Join Trial
Haploidentical Transplant With NK Cell Infusion for Pediatric Acute Leukemia and Solid Tumors PHASE1 This study will assess the feasibility of utilizing a reduced intensity con...
Show More Location
Kenneth DeSantes., MD
Learn More & Join Trial
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant PHASE2 RATIONALE: Giving chemotherapy, such as busulfan and fludarabine phosphate,...
Show More Location
Tunnell Cancer Center at Beebe Medical Center
Learn More & Join Trial
Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT PHASE1 Evaluate the safety of natural killer (NK) cell infusion using CD56 monoclo...
Show More Location
Duke University Health Systems
Learn More & Join Trial
Expanded Natural Killer Cells Following Haploidentical HSCT for AML/MDS PHASE1 The study examines the application of expanded natural killer cells (NK cel...
Show More Location
University Hospital Basel
Learn More & Join Trial
Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation PHASE1 The goal of our study will be to determine the clinical and biological safe...
Show More Location
Institut Paoli-Calmettes
Learn More & Join Trial